The development of the next generation ofAlzheimer’s disease treatments is among the most important health needsworldwide, but presents huge challenges. The goal of the meeting is to bringtogether today’s worldwide leaders in the treatment of Alzheimer’s disease todiscuss new results, candidate therapeutics, and methodological issuesimportant to the development of the next generation of Alzheimer’s diseasetreatments.

Clinical trial teamsfrom worldwide centers will report on their efforts to identify new biomarkersof disease as well as more sensitive clinical assessment tools to identifythose at risk for AD, to predict progression, and assess the effectiveness ofnew treatments

Overall, the aim of theconference is to overcome the hurdles and speed the development of effectivetreatments.